These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 10355514)

  • 1. A sclerosant with astringent properties developed in China for oesophageal varices: comparison with ethanolamine oleate and polidocanol.
    Nishida R; Inoue R; Takimoto Y; Kita T
    J Gastroenterol Hepatol; 1999 May; 14(5):481-8. PubMed ID: 10355514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endoscopic sclerotherapy in a rat model of esophageal varices.
    Nishida R; Inoue R; Takimoto Y; Hamashima H; Kita T
    Scand J Gastroenterol; 1995 May; 30(5):489-96. PubMed ID: 7638578
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative effects of 5% ethanolamine oleate versus 5% ethanolamine oleate plus 1% polidocanol for sclerosing esophageal varices.
    Kitano S; Wada H; Tanoue K; Hashizume M; Koyanagi N; Sugimachi K
    Hepatogastroenterology; 1992 Dec; 39(6):546-8. PubMed ID: 1483669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Balloon-Occluded Retrograde Transvenous Obliteration for the Treatment of Gastric Varices: Polidocanol Foam Versus Liquid Ethanolamine Oleate.
    Itou C; Koizumi J; Hashimoto T; Myojin K; Kagawa T; Mine T; Imai Y
    AJR Am J Roentgenol; 2015 Sep; 205(3):659-66. PubMed ID: 26295655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of ethanolamine and polidocanol in the eradication of esophageal varices. A prospective randomized trial.
    Balanzó J; Sainz S; Espinós JC; Such J; Segura J; Guarner C; Cussó X; Vilardell F
    Endoscopy; 1989 Nov; 21(6):251-3. PubMed ID: 2693076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ethanolamine oleate is superior to polidocanol (aethoxysklerol) for endoscopic injection sclerotherapy of esophageal varices: a prospective randomized trial.
    Kitano S; Iso Y; Koyanagi N; Higashi H; Sugimachi K
    Hepatogastroenterology; 1987 Feb; 34(1):19-23. PubMed ID: 3552917
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Studies on the damage of the cultured endothelial cells and K-562 cells by sclerosants (ethanolamine oleate, Aethoxysklerol and absolute ethanol) used in the treatment of esophageal varices].
    Orikasa K
    Nihon Shokakibyo Gakkai Zasshi; 1989 Oct; 86(10):2365-72. PubMed ID: 2593306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immediate endoscopic injection therapy of bleeding oesophageal varices: a prospective comparative evaluation of injecting materials in Egyptian patients with portal hypertension.
    Omar MM; Fakhry SM; Mostafa I
    J Egypt Soc Parasitol; 1998 Apr; 28(1):159-68. PubMed ID: 9617052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prediction of the recurrence of esophageal varices based on portal vein pressure and oxygen tension in portal and peripheral blood.
    Obara K; Sakamoto H; Kasukawa R
    Gastroenterol Jpn; 1991 Dec; 26(6):707-11. PubMed ID: 1765244
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prospective randomized comparison of sodium tetradecyl sulphate & polidocanol for oesophageal variceal sclerotherapy.
    Ravi M; Kate V; Ananthakrishnan N
    Indian J Med Res; 2001 Jun; 113():228-33. PubMed ID: 11816957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differences in hemostasis among sclerosing agents in endoscopic injection sclerotherapy.
    Tatemichi M; Nagata H; Sekizuka E; Morishita T; Miyairi M; Tsuchiya M; Ishii H
    Dig Dis Sci; 1996 Mar; 41(3):562-70. PubMed ID: 8617137
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Injection sclerotherapy for gastric varices using N-butyl-2-cyanoacrylate and ethanolamine oleate.
    Miyazaki S; Yoshida T; Harada T; Shigemitsu T; Takeo Y; Okita K
    Hepatogastroenterology; 1998; 45(22):1155-8. PubMed ID: 9756025
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endoscopic sclerotherapy of oesophageal varices due to hepatosplenic schistosomiasis. A randomized controlled trial evaluating effect of sclerosant concentration.
    Dowidar N; Hafez A
    J Egypt Soc Parasitol; 2002 Aug; 32(2):537-49. PubMed ID: 12214931
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ethanolamine oleate versus butyl cyanoacrylate for bleeding gastric varices: a nonrandomized study.
    Oho K; Iwao T; Sumino M; Toyonaga A; Tanikawa K
    Endoscopy; 1995 Jun; 27(5):349-54. PubMed ID: 7588347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative effects of 5% ethanolamine oleate versus 5% sodium morrhuate for sclerotherapy of oesophageal varices.
    Kitano S; Wada H; Yamaga H; Hashizume M; Koyanagi N; Iwanaga T; Iso Y; Sugimachi K
    J Gastroenterol Hepatol; 1991; 6(5):476-80. PubMed ID: 1932669
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Albumin inhibits hemolysis of erythrocytes induced by ethanolamine oleate during endoscopic injection sclerotherapy.
    Ohta M; Hashizume M; Ueno K; Tanoue K; Sugimachi K
    Hepatogastroenterology; 1993 Feb; 40(1):65-8. PubMed ID: 8462932
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Human thrombin plus 5 per cent ethanolamine oleate injected to sclerose oesophageal varices: a prospective randomized trial.
    Kitano S; Hashizume M; Yamaga H; Wada H; Iso Y; Iwanaga T; Sugimachi K
    Br J Surg; 1989 Jul; 76(7):715-8. PubMed ID: 2765808
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oesophageal stricture and dysphagia after endoscopic sclerotherapy for bleeding varices.
    Sørensen T; Burcharth F; Pedersen ML; Findahl F
    Gut; 1984 May; 25(5):473-7. PubMed ID: 6609102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-butyl-2-cyanoacrylate (Histoacryl) plus sclerotherapy versus sclerotherapy alone in the treatment of bleeding esophageal varices: a randomized prospective study.
    Feretis C; Dimopoulos C; Benakis P; Kalliakmanis B; Apostolidis N
    Endoscopy; 1995 Jun; 27(5):355-7. PubMed ID: 7588348
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prophylactic sclerotherapy of oesophageal varices: is it justified?
    Lancet; 1988 Jun; 1(8599):1369-70. PubMed ID: 2898047
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.